Analystreport

Juno Therapeutics, Inc. (NASDAQ: JUNO) had its "reduce" rating re-affirmed by analysts at Standpoint Research.

JUNO THERAPEUTICS  (JUNO) 
Last juno therapeutics earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.junotherapeutics.com/investor-relations